TREA

79329443 - LIVITECH

Follow

Information

  • Trademark
  • 79329443
  • Serial Number
    79329443
  • Registration Number
    7033146
  • Filing Date
    October 21, 2021
    3 years ago
  • Registration Date
    April 25, 2023
    2 years ago
  • Transaction Date
    August 03, 2023
    a year ago
  • Status Date
    April 25, 2023
    2 years ago
  • Published for Opposition Date
    February 07, 2023
    2 years ago
  • Location Date
    April 25, 2023
    2 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    MCGILL, CIERRA L
  • Attorney Docket Number
    N&P-51853
    Attorney Name
    Ronald M. Kachmarik
    Law Office Assigned Location Code
    M10
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
LIVITECH
Case File Statements
  • GS0091: Downloadable software for use in diagnosis of inflammatory diseases and liver diseases; downloadable software applications for use in diagnosing medical conditions; scientific apparatus and instruments especially for recording, processing, reproducing, transmitting data, namely, electronic data loggers and recorders; data processing equipment; all these goods exclusively in the field of innovative therapeutic and diagnostic solutions in metabolic and liver related diseases; and none of them related to telemedicines services, online medical consultation and online medical assistance provided to the public
  • GS0051: Pharmaceuticals for use in human or veterinary medicine, for scientific use for the treatment of inflammatory diseases and liver diseases; chemical preparations for use in human or veterinary medicine, or for pharmaceutical use, namely, for the treatment of inflammatory diseases and liver diseases; biological preparations for use in human or veterinary medicine, or for pharmaceutical use, namely, for the treatment of inflammatory diseases and liver diseases; preparations for use in human or veterinary medicine, or for pharmaceutical use, namely, for the treatment of inflammatory diseases and liver diseases; microorganism cultures for use in human or veterinary medicine, or for pharmaceutical use; cell preparations for use in human or veterinary medicine, or for pharmaceutical use, in particular for gene therapy and cell therapy, namely, cell growth media; blood and blood derived samples, namely, plasma, serum, platelet free samples for medical use; diagnostic biomarker reagent products for use in human or veterinary medicine; diagnostic reagents for use in human or veterinary medicine; all these goods exclusively in the field of innovative therapeutic and diagnostic solutions in metabolic and liver related diseases; and none of them related to telemedicines services, online medical consultation and online medical assistance provided to the public
  • GS0011: Reagents for chemical analyses for scientific use; reagents for scientific use; reagents for scientific or medical research use; diagnostic reagents for scientific use; reagents for immunoserology and molecular diagnosis for research use; chemical reagents for genetic research; in-vivo diagnostic reagents for scientific use; diagnostic reagents for scientific use or for research use; diagnostic reagents for in-vitro use in biochemistry, molecular biology, clinical chemistry and microbiology for research use; all these goods exclusively in the field of innovative therapeutic and diagnostic solutions in metabolic and liver related diseases; and none of them related to telemedicines services, online medical consultation and online medical assistance provided to the public
  • GS0441: Medical analysis relating to the diagnosis and treatment of persons and medical diagnosis services in inflammatory diseases and liver diseases; medical analyses of blood samples, biological preparations and biological fluids relating to the diagnosis and treatment of persons; support services in the field of medicine, health care and pharmaceutical research, namely, medical analysis for the diagnosis and treatment of patients; medical information; provision of medical information; all these services exclusively in the field of innovative therapeutic and diagnostic solutions in metabolic and liver related diseases; and none of them related to telemedicines services, online medical consultation and online medical assistance provided to the public
  • GS0101: Medical apparatus, instruments and equipment, namely, DNA, RNA and protein analysis apparatus, DNA, RNA and protein quantifiers, medical devices for measuring DNA, RNA, biochemical and physical parameters, namely, concentration of biomarkers relating to the evaluation of inflammatory and liver diseases and blood analyzers for evaluation of inflammatory and liver diseases; instruments and tools for medical diagnosis, namely, computer displays and computer monitors and controllers therefor used in direct association with medical diagnosis apparatus during the process of diagnosis of a condition in an individual; diagnostic apparatus for medical use, namely, medical diagnostic apparatus for testing the biomarker levels; all these goods exclusively in the field of innovative therapeutic and diagnostic solutions in metabolic and liver related diseases; and none of them related to telemedicines services, online medical consultation and online medical assistance provided to the public
  • GS0421: Pharmaceutical research, namely, research for the discovery of new medicines; scientific research, especially in the medical, biomedical, chemical, genetic, pharmaceutical field; basic and applied scientific research; technical scientific research; scientific research, namely, sorting and selection of molecules; scientific research services, namely, development and validation of biological tests, cellular tests and genetic tests; scientific research, namely, functional genomics for identifying, characterizing, validating and developing biologically active molecules; analysis of biological substances in biological fluids; computer programming in the field of scientific research and for the pharmaceutical industry; engineering services, namely, surveying; technical project study being scientific research; professional consultancy unrelated to business dealings in the field of scientific and medical research; research and development of new pharmaceutical products for others; scientific research in the field of pharmacy; all these services exclusively in the field of innovative therapeutic and diagnostic solutions in metabolic and liver related diseases; and none of them related to telemedicines services, online medical consultation and online medical assistance provided to the public
Case File Event Statements
  • 8/3/2023 - a year ago
    31 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 8/3/2023 - a year ago
    30 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 7/25/2023 - a year ago
    29 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 4/25/2023 - 2 years ago
    28 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 4/25/2023 - 2 years ago
    27 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 2/7/2023 - 2 years ago
    26 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 2/7/2023 - 2 years ago
    25 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 2/7/2023 - 2 years ago
    24 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 1/18/2023 - 2 years ago
    23 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 1/18/2023 - 2 years ago
    22 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 1/18/2023 - 2 years ago
    21 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 1/17/2023 - 2 years ago
    20 - ASSIGNED TO EXAMINER Type: DOCK
  • 12/31/2022 - 2 years ago
    19 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 12/31/2022 - 2 years ago
    18 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 12/31/2022 - 2 years ago
    17 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 12/31/2022 - 2 years ago
    16 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 12/31/2022 - 2 years ago
    15 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 11/27/2022 - 2 years ago
    14 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 11/27/2022 - 2 years ago
    13 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 10/24/2022 - 2 years ago
    12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 10/24/2022 - 2 years ago
    11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 10/24/2022 - 2 years ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 5/16/2022 - 2 years ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 4/28/2022 - 2 years ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 4/28/2022 - 2 years ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 3/18/2022 - 3 years ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 3/17/2022 - 3 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 3/17/2022 - 3 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 1/7/2022 - 3 years ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 1/3/2022 - 3 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 12/23/2021 - 3 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR